» Articles » PMID: 38041005

Association Between Fatty Acid Metabolism Gene Mutations and Mycobacterium Tuberculosis Transmission Revealed by Whole Genome Sequencing

Overview
Journal BMC Microbiol
Publisher Biomed Central
Specialty Microbiology
Date 2023 Dec 1
PMID 38041005
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Fatty acid metabolism greatly promotes the virulence and pathogenicity of Mycobacterium tuberculosis (M.tb). However, the regulatory mechanism of fatty acid metabolism in M.tb remains to be elucidated, and limited evidence about the effects of gene mutations in fatty acid metabolism on the transmission of M.tb was reported.

Results: Overall, a total of 3193 M.tb isolates were included in the study, of which 1596 (50%) were genomic clustered isolates. Most of the tuberculosis isolates belonged to lineage2(n = 2744,85.93%), followed by lineage4(n = 439,13.75%) and lineage3(n = 10,0.31%).Regression results showed that the mutations of gca (136,605, 317G > C, Arg106Pro; OR, 22.144; 95% CI, 2.591-189.272), ogt(1,477,346, 286G > C ,Gly96Arg; OR, 3.893; 95%CI, 1.432-10.583), and rpsA (1,834,776, 1235 C > T, Ala412Val; OR, 3.674; 95% CI, 1.217-11.091) were significantly associated with clustering; mutations in gca and rpsA were also significantly associated with clustering of lineage2. Mutation in arsA(3,001,498, 885 C > G, Thr295Thr; OR, 6.278; 95% CI, 2.508-15.711) was significantly associated with cross-regional clusters. We also found that 20 mutation sites were positively correlated with cluster size, while 11 fatty acid mutation sites were negatively correlated with cluster size.

Conclusion: Our research results suggested that mutations in genes related to fatty acid metabolism were related to the transmission of M.tb. This research could help in the future control of the transmission of M.tb.

Citing Articles

Correction: Association between fatty acid metabolism gene mutations and Mycobacterium tuberculosis transmission revealed by whole genome sequencing.

Li Y, Kong X, Li Y, Tao N, Wang T, Li Y BMC Microbiol. 2024; 24(1):2.

PMID: 38172663 PMC: 10763435. DOI: 10.1186/s12866-023-03158-4.

References
1.
Rylance J, Pai M, Lienhardt C, Garner P . Priorities for tuberculosis research: a systematic review. Lancet Infect Dis. 2010; 10(12):886-92. PMC: 2992175. DOI: 10.1016/S1473-3099(10)70201-2. View

2.
Linh N, Viney K, Gegia M, Falzon D, Glaziou P, Floyd K . World Health Organization treatment outcome definitions for tuberculosis: 2021 update. Eur Respir J. 2021; 58(2). DOI: 10.1183/13993003.00804-2021. View

3.
Atamna-Mawassi H, Huberman-Samuel M, Hershcovitz S, Karny-Epstein N, Kola A, Lopez Cortes L . Interventions to reduce infections caused by multidrug resistant Enterobacteriaceae (MDR-E): A systematic review and meta-analysis. J Infect. 2021; 83(2):156-166. DOI: 10.1016/j.jinf.2021.05.005. View

4.
Van Rie A, Enarson D . XDR tuberculosis: an indicator of public-health negligence. Lancet. 2006; 368(9547):1554-6. DOI: 10.1016/S0140-6736(06)69575-5. View

5.
Singh V, Mani I, Chaudhary D, Somvanshi P . The β-ketoacyl-ACP synthase from Mycobacterium tuberculosis as potential drug targets. Curr Med Chem. 2011; 18(9):1318-24. DOI: 10.2174/092986711795029636. View